Published • loading... • Updated
Two Child Deaths in China Gene Trials Spur Tighter Rules
The cases have raised questions about ethics, transparency and oversight, and could lead China to tighten rules for gene-editing trials.
Summary
2 Articles
2 Articles
Two children died from gene therapies in China: where the field goes next
Nature, Published online: 08 September 2026; doi:10.1038/d41586-026-02497-2Strengthened laws should help to ensure future deaths are quickly disclosed to the public, but China’s reputation for such research is at risk.
·London, United Kingdom
Read Full Article
The deaths of two children in two separate gene therapy trials in China raise serious questions about surveillance and could have a profound impact on the country's biomedical industry, researchers, ethicists and legal scholars say. On August 5, Shanghai-based gene therapy company HuidaGene Therapeutics announced that it had lost the life of a little boy in 2025 during one of their clinical trials. And in July, an investigation by Science and Re…
Coverage Details
Total News Sources2
Leaning Left0Leaning Right0Center1Last UpdatedBias Distribution100% Center
Bias Distribution
- 100% of the sources are Center
100% Center
C 100%
Factuality
To view factuality data please Upgrade to Premium
